Monda, Vincenzo M.
Voci, Claudio
Strollo, Felice http://orcid.org/0000-0001-8917-5314
Passaro, Angelina
Greco, Salvatore
Monesi, Marcello
Bigoni, Renato
Porcellati, Francesca
Piani, Daniela
Satta, Ersilia
Gentile, Sandro
Article History
Received: 24 July 2023
Accepted: 31 August 2023
First Online: 6 October 2023
Declarations
:
: Vincenzo M. Monda, Claudio Voci, Felice Strollo, Angela Passaro, Salvatore Greco, Marcello Monesi, Renato Bigoni, Francesca Porcellati, Daniela Piani, Ersilia Satta, and Sandro Gentile have no financial interests to declare concerning the present study.
: This study complied with good clinical practice standards and followed the ethical guidelines of the 1964 Declaration of Helsinki and its subsequent amendments. The study protocol was approved by the IRB (trial registration: Protocol n. 5, May 16, 2022) and the Ethical and Scientific Committee of the reference center, the Department of Endocrinology, San Raffaele Pisana Cliical Research Institute, Rome, Italy, served as the central reference ethical committee for all of the participating affiliated medical units. All subjects with T2DM who participated in the study signed an informed consent form before being included in the present investigation.